Yao-Chi Chuang Selected Research

Yao-Chi Chuang Research Topics

Disease

18	Overactive Urinary Bladder (Overactive Bladder) 03/2022 - 10/2008
14	Pain (Aches) 04/2022 - 01/2003
12	Interstitial Cystitis (Interstitial Cystitis, Chronic) 03/2022 - 01/2003
11	Inflammation (Inflammations) 03/2022 - 04/2007
11	Lower Urinary Tract Symptoms 01/2022 - 07/2006
9	Prostatic Hyperplasia (Benign Prostatic Hyperplasia) 10/2019 - 10/2005
7	Prostatitis 04/2022 - 12/2006
7	Shock 03/2022 - 08/2016
7	Cystitis 01/2022 - 09/2008
5	Neoplasms (Cancer) 03/2022 - 07/2009
5	Hypertension (High Blood Pressure) 01/2022 - 04/2012
5	Underactive Urinary Bladder 04/2019 - 01/2014
4	Nocturia 01/2022 - 07/2014
4	Urinary Tract Infections (Urinary Tract Infection) 01/2021 - 06/2014
3	Erectile Dysfunction 03/2022 - 08/2016
3	Stress Urinary Incontinence 03/2022 - 09/2011
3	Urge Urinary Incontinence (Urge Incontinence) 01/2021 - 08/2014
3	Neoplasm Metastasis (Metastasis) 01/2021 - 07/2009
3	Infections 01/2020 - 10/2009
3	Prostatic Neoplasms (Prostate Cancer) 09/2016 - 07/2009
3	Stroke (Strokes) 08/2016 - 07/2013
2	Constipation 10/2022 - 01/2021
2	Carcinoma (Carcinomatosis) 01/2021 - 12/2011
2	Urinary Bladder Neck Obstruction (Bladder Neck Obstruction) 05/2020 - 04/2006
2	Hemorrhage 11/2019 - 11/2018
2	Ataxia (Dyssynergia) 10/2019 - 12/2006
2	Hypersensitivity (Allergy) 09/2019 - 07/2009
2	Urinary Retention 12/2014 - 11/2006
2	Metabolic Syndrome (Dysmetabolic Syndrome X) 07/2013 - 04/2012
2	Hemorrhagic Cystitis 06/2013 - 04/2013
2	Atrophy 10/2009 - 04/2006
1	Pelvic Pain 03/2022
1	Mitochondrial Diseases (Mitochondrial Disease) 01/2022
1	Nervous System Diseases (Neurological Disorders) 01/2022
1	Urinary Calculi (Urinary Calculus) 09/2021
1	Urologic Neoplasms (Urological Cancer) 09/2021
1	Dysuria 01/2021
1	Fibrosis (Cirrhosis) 11/2019
1	Hyperalgesia 09/2019
1	Edema (Dropsy) 09/2019
1	Heart Diseases (Heart Disease) 11/2018

Drug/Important Bio-Agent (IBA)

17	Type A Botulinum Toxins (Botox)FDA Link 12/2021 - 10/2004
8	Liposomes (Liposome)IBA 01/2020 - 10/2009
7	Pharmaceutical PreparationsIBA 03/2022 - 03/2006
7	incobotulinumtoxinA FDA Link 10/2019 - 11/2006
5	Capsaicin (Zostrix)FDA Link 04/2022 - 04/2005
5	Botulinum Toxins (Botulinum Toxin)IBA 08/2016 - 12/2006
3	Solifenacin Succinate FDA Link 10/2022 - 10/2008
3	4-amino-4'-hydroxylaminodiphenylsulfone (HADS)IBA 01/2022 - 11/2017
3	Therapeutic UsesIBA 09/2019 - 09/2013
3	Analgesics (Analgesic Drugs)IBA 08/2017 - 01/2003
3	Testosterone (Sustanon)FDA Link 08/2016 - 07/2012
3	C-Reactive ProteinIBA 07/2014 - 04/2012
3	Cyclophosphamide (Cytoxan)FDA LinkGeneric 03/2011 - 07/2009
3	ProstaglandinsIBA 12/2010 - 08/2008
2	Cisplatin (Platino)FDA LinkGeneric 03/2022 - 09/2021
2	Ketamine FDA LinkGeneric 11/2019 - 11/2018
2	Substance PIBA 11/2019 - 11/2018
2	Nerve Growth Factor (NGF)IBA 08/2017 - 01/2014
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2017 - 01/2014
2	Prostate-Specific Antigen (Semenogelase)IBA 09/2016 - 07/2009
2	AndrogensIBA 08/2016 - 07/2013
2	Acetic Acid (Vinegar)FDA LinkGeneric 08/2016 - 10/2004
2	CreatinineIBA 08/2016 - 07/2014
2	Hemoglobins (Hemoglobin)IBA 07/2014 - 04/2012
2	Serum AlbuminIBA 07/2014 - 07/2012
2	Dinoprostone (PGE2)FDA Link 01/2014 - 03/2011
2	Tacrolimus (Prograf)FDA LinkGeneric 04/2013 - 03/2011
2	Protective AgentsIBA 10/2011 - 10/2009
2	Prostaglandins EIBA 12/2010 - 07/2009
2	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 07/2009 - 08/2008
2	Opioid Peptides (Opioid Peptide)IBA 04/2005 - 11/2003
2	Complementary DNA (cDNA)IBA 04/2005 - 11/2003
1	Cytochromes c (Cytochrome c)IBA 01/2022
1	Caspase 3 (Caspase-3)IBA 01/2022
1	imidafenacinIBA 01/2021
1	Biomarkers (Surrogate Marker)IBA 01/2021
1	indolepropanol phosphate (IPP)IBA 05/2020
1	Protamines (Protamine Sulfate)FDA Link 01/2020
1	phosphatidylethanolamineIBA 01/2020
1	mirabegronIBA 01/2020
1	HydrogelsIBA 01/2020
1	Hyaluronic Acid (Hyaluronan)IBA 01/2020
1	Uroplakin IIIIBA 11/2019
1	hachimijiogan (TJ 7)IBA 11/2019
1	die-huang-wanIBA 11/2019
1	Proteins (Proteins, Gene)FDA Link 11/2018
1	Cadherins (E-Cadherin)IBA 11/2018
1	Interleukin-6 (Interleukin 6)IBA 08/2017

Therapy/Procedure

13	Therapeutics 03/2022 - 09/2008
9	Extracorporeal Shockwave Therapy 04/2022 - 01/2017
4	Intravesical Administration 01/2017 - 10/2009
3	Drug Therapy (Chemotherapy) 09/2021 - 06/2013
2	Nephroureterectomy 01/2021 - 12/2011
2	Injections 01/2017 - 09/2008
2	Blood Transfusion (Blood Transfusions) 07/2011 - 03/2010
2	Analgesia 04/2005 - 10/2004
1	Lithotripsy (Extracorporeal Shockwave Lithotripsy) 09/2021
1	Oral Administration 01/2021
1	Anesthesia 01/2020